These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 24927088)

  • 1. Comparative efficacy and tolerability among different selective serotonin re-uptake inhibitors and venlafaxine in a naturalistic setting.
    Arias F; Padín JJ; Gilaberte I; Varillas P; Sánchez R; Gómez S; García D
    Int J Psychiatry Clin Pract; 1998; 2(4):255-60. PubMed ID: 24927088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative naturalistic study of the efficacy and tolerability of new antidepressants].
    Arias F; Padín JJ; Gilaberte I; Varillas P; Sánchez R; Gómez S; García D
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(6):351-7. PubMed ID: 9972586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A naturalistic study on the criteria of choice of second-generation antidepressants: A comparison of venlafaxine and SSRIs in depressed inpatients.
    Dorz Sabrina Cognolato Donatella Conforti Caterina Scarso Giuseppe Borgherini S
    Int J Psychiatry Clin Pract; 2001; 5(3):173-8. PubMed ID: 24926750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].
    Favré P
    Encephale; 2012 Feb; 38(1):86-96. PubMed ID: 22381728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
    Davidson JR; Meoni P; Haudiquet V; Cantillon M; Hackett D
    Depress Anxiety; 2002; 16(1):4-13. PubMed ID: 12203668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double-blind, randomised 6-month comparative trial with citalopram.
    Allard P; Gram L; Timdahl K; Behnke K; Hanson M; Søgaard J
    Int J Geriatr Psychiatry; 2004 Dec; 19(12):1123-30. PubMed ID: 15526307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of long-term tolerability in achieving recovery.
    Baldwin DS
    Int J Psychiatry Clin Pract; 2006; 10 Suppl 1():31-7. PubMed ID: 24931542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative safety and tolerability of selective serotonin reuptake inhibitors.
    Devane CL
    Hum Psychopharmacol; 1995 Oct; 10 Suppl 3(S3):S185-S193. PubMed ID: 29569415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Side Effect Profiles of Selective Serotonin Reuptake Inhibitors: A Cross-Sectional Study in a Naturalistic Setting.
    Anagha K; Shihabudheen P; Uvais NA
    Prim Care Companion CNS Disord; 2021 Jul; 23(4):. PubMed ID: 34324797
    [No Abstract]   [Full Text] [Related]  

  • 11. Do Hospital and Community SSRI Usage Patterns in Children and Adolescents Match the Evidence?
    Ronsley R; Elbe D; Smith DH; Garland EJ
    J Can Acad Child Adolesc Psychiatry; 2010 Aug; 19(3):218-26. PubMed ID: 20842278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of selective serotonin re-uptake inhibitors (SSRIs) in the treatment of panic disorder with and without agoraphobia.
    Boerner RJ; Möller HJ
    Int J Psychiatry Clin Pract; 1997; 1(1):59-67. PubMed ID: 24926982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sexual dysfunctions induced by serotonin reuptake inhibitors].
    Arias F; Padín JJ; Rivas MT; Sánchez A
    Aten Primaria; 2000 Oct; 26(6):389-94. PubMed ID: 11111311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective cohort study of venlafaxine, fluoxetine or sertraline in long-term care.
    Blake LM; Wan GJ; Panish JM; Buatti MC
    Clin Drug Investig; 2003; 23(11):735-42. PubMed ID: 17536887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the efficacy and tolerability of venlafaxine.
    Dierick M
    Eur Psychiatry; 1997; 12 Suppl 4():307s-13s. PubMed ID: 19698585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visualizing Patterns of Medication Switching Among Major Depressive Patients with Various Stability and Difficulty to Treatments.
    Hung YC; Chen HC; Kuo PH; Lu ML; Huang MC; Chen CH; Wang S; Mao WC; Wu CS; Wu TH
    Neuropsychiatr Dis Treat; 2021; 17():1953-1963. PubMed ID: 34168454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review on hyponatremia associated with SSRIs, reboxetine and venlafaxine.
    Egger C; Muehlbacher M; Nickel M; Geretsegger C; Stuppaeck C
    Int J Psychiatry Clin Pract; 2006; 10(1):17-26. PubMed ID: 24926764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant-Induced Sexual Dysfunction among Newer Antidepressants in a Naturalistic Setting.
    Lee KU; Lee YM; Nam JM; Lee HK; Kweon YS; Lee CT; Jun TY
    Psychiatry Investig; 2010 Mar; 7(1):55-9. PubMed ID: 20396434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum 3-Hydroxybutyrate in Patients with Psychogenic Somatoform Symptoms May Be a Predictor of the Effectiveness of Sertraline and Venlafaxine.
    Saito N; Itoga M; Minakawa S; Kayaba H
    Int J Gen Med; 2021; 14():1785-1795. PubMed ID: 34007205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum N-Desmethylcitalopram Concentrations are Associated with the Clinical Response to Citalopram of Patients with Major Depression.
    Ozbey G; Yucel B; Bodur NE; Taycan SE; Arslan T; Cerit N; Yuksel N; Guzey IC; Uluoglu C
    Psychiatry Investig; 2018 Mar; 15(3):313-319. PubMed ID: 29475241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.